MorphoSys (MOR)
(Delayed Data from NSDQ)
$18.14 USD
-0.04 (-0.22%)
Updated Mar 27, 2024 04:00 PM ET
1-Strong Buy of 5 1
F Value F Growth A Momentum F VGM
MorphoSys AG Unsponsored ADR (MOR) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$11.54 | $18.25 | $4.75 | -36.38% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for MorphoSys AG Unsponsored ADR comes to $11.54. The forecasts range from a low of $4.75 to a high of $18.25. The average price target represents a decline of 36.38% from the last closing price of $18.14.
Analyst Price Targets (5 )
Broker Rating
MorphoSys AG Unsponsored ADR currently has an average brokerage recommendation (ABR) of 2.39 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by nine brokerage firms. The current ABR compares to an ABR of 2.17 a month ago based on nine recommendations.
Of the nine recommendations deriving the current ABR, three are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 33.33% and 11.11% of all recommendations. A month ago, Strong Buy made up 44.44%, while Buy represented 11.11%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 4 | 4 | 4 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 4 | 4 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 2.39 | 2.39 | 2.17 | 2.17 | 2.17 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
3/14/2024 | JMP Securities | Jason N Butler | Strong Buy | Strong Buy |
3/14/2024 | SVB Securities | Andrew Berens | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.39 |
ABR (Last week) | 2.39 |
# of Recs in ABR | 9 |
Average Target Price | $11.54 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 80 of 252 |
Current Quarter EPS Est: | -0.51 |